Evidence map›Paper›PMID 42243595›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2026

Correction to: a novel tsRNA, tRF-33-6978WPRLXN4V0O inhibits breast cancer development via regulating PTEN/AKT pathway in BHLHA15 mediated manner.

Ji Dai, Haoqiang Ji, Huihui Bai, Qilong Zhong, Haohang Sun, Mengze Chen, Qi Chen, Meidi Yan, Dandan Zhang, Shuangshuang Zhang

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ji DaiThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China.
Haoqiang JiDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Ningbo University, 315211, Ningbo, People's Republic of China.
Huihui BaiDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Ningbo University, 315211, Ningbo, People's Republic of China.
Qilong ZhongThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China.
Haohang SunThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China.
Mengze ChenThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China.
Qi ChenThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China.
Meidi YanThe First Department of General Surgery, Ningbo Zhenhai People's Hospital, 315202, Ningbo, Zhejiang, People's Republic of China. zhyanmeidi@126.com.
Dandan ZhangDepartment of Pharmacy, The First Affiliated Hospital of Ningbo University, 315020, Ningbo, People's Republic of China. fyzhangdandan@nbu.edu.cn.
Shuangshuang ZhangNingbo Institute of Innovation for Combined Medicine and Engineering, The Affiliated Lihuili Hospital of Ningbo University, 315040, Ningbo, Zhejiang, People's Republic of China. lhlzhangshuangshuang@nbu.edu.cn.ORCID http://orcid.org/0009-0000-2944-4615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42243595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.